Friday, 11 March 2011 09:38
News - Chitosan Publications
Publications in February 2011
In the februar of this year 81 papers about chitosan and its derivates were published. As in the months before also in February china was with 21 publications the most active country in this field of research followed by the USA with 12 publications and India with 4.
The most frequent keywords in the papers about chitosan and its derivates were nanoparticles (23 publications), microscopy, hydrogen-ion concentration and tissues (each with 19 publications). In the table below the 5 journals with the most publications about chitosan and its derivates are listed.
| Top Journals | Publications |
| Colloids Surf B Biointerfaces | 13 |
| Int J Pharm |
4 |
| Int J Biol Macromol |
4 |
| Biomacromolecules |
4 |
| Biomaterials |
4 |
Following three publications about properties and application of chitosan from February shall be shortly presented.
Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption.
Authors: Mo, Ran, Xiao, Yanyu, Sun, Minjie, Zhang, Can, Ping, Qineng
Journal: International journal of pharmaceutics, 2011
Etoposide (VP16) is a substrate of the p-glycoprotein (P-gp) which is expressed in the apical membranes of the epithelial cells of the intestine and is responsible for reducing oral bioavailability of a wide range of drugs. Mo et al. analyzed the effect of N-octyl-O-sulfate chitosan (NOSC) on the absorption of etoposide. Different concentrations of NOSC are able to increase the intestinal absorption of VP16 in rat jejunum and ileum and the VP16 uptake of Caco-2 cells. There were no differences observed in comparison to other P-gp inhibitors. By using NOSC at a concentration close to its critical micelle concentration the group found a cell uptake of VP16 which reached to the maximum value. NOSC exhibited the ability to increase the transport of VP16 from apical side to basolateral side whereas from basolateral to apical side the transport was decreased.
PMID: 21356302 Related Articles
A self-assembling hydrophobically modified chitosan capable of reversible hemostatic action.
Authors: Dowling, Matthew B, Kumar, Rakesh, Keibler, Mark A, Hess, John R, Bochicchio, Grant, Raghavan, Srinivasa R
Journal: Biomaterials, 2011
The working group of Dowling used a hydrophobically modified (hm) derivative of chitosan to transform blood rapidly into a gelled clot. They showed that this process can be reversed by the use of a sugar-based supramolecule like α-cyclodextrin. The contact of hm chitosan with heparinized human blood resulted in a rapidly transformation of the blood into an elastic gel. Native chitosan didn´t function in that way. Dowling et al. proved that hm chitosan is able to accelerate hemostasis in small and large animal injury models. Hm chitosan could serve as an effective, low cost hemostatic dressing.
PMID: 21296412 Related Articles
A glucose biosensor based on chitosan-Prussian blue-multiwall carbon nanotubes-hollow PtCo nanochains formed by one-step electrodeposition.
Authors: Che, Xin, Yuan, Ruo, Chai, Yaqin, Li, Jingjing, Song, Zhongju, Li, Wenjuan, Zhong, Xia
Journal: Colloids and surfaces. B, Biointerfaces, 2011
